2024-22575. Agency Information Collection Activities; Proposed Collection; Comment Request; Promotion of Prescription Drugs Within a Talk Show Format

Table 1—Study Experimental Design

Sponsorship prominence	Endorser type and risk prominence
	Patient guest		Physician guest
	Higher risk prominence	Lower risk prominence	Higher risk prominence	Lower risk prominence
None.
Once.
Periodic.
Constant.

Following the video, respondents will be asked questions pertaining to their recall and comprehension of risks and benefits depicted in the advertisement, perceptions of endorser characteristics, perceptions of drug qualities, and behavioral intentions.

We estimate the burden of this collection of information as follows: ( print page 80255)

Table 2—Estimated Annual Reporting Burden ¹

Activity	Number of respondents	Number of responses per respondent	Total annual responses	Average burden per response 2	Total hours
Pretest
Pretest Screener Completes	400	1	400	0.03 (2 minutes)	12
Pretest Questionnaire Completes	80	1	80	0.30 (18 minutes)	24
Main Study
Main Study Screener Completes	3,200	1	3,200	0.03 (2 minutes)	96
Main Study Questionnaire Completes	640	1	640	0.30 (18 minutes)	192
Total					324
1  There are no capital costs or operating and maintenance costs associated with this collection of information.
2  Burden estimates of less than 1 hour are expressed as a fraction of an hour in decimal format.